Research progress on the pharmacological mechanisms of chinese medicines that tonify Qi and activate blood against cerebral ischemia/reperfusion injury

IF 4.3 3区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE World Journal of Traditional Chinese Medicine Pub Date : 2022-04-01 DOI:10.4103/wjtcm.wjtcm_21_21
Xiao-yu Zheng, Yehao Zhang, Wenting Song, D. Chang, Jian-xun Liu
{"title":"Research progress on the pharmacological mechanisms of chinese medicines that tonify Qi and activate blood against cerebral ischemia/reperfusion injury","authors":"Xiao-yu Zheng, Yehao Zhang, Wenting Song, D. Chang, Jian-xun Liu","doi":"10.4103/wjtcm.wjtcm_21_21","DOIUrl":null,"url":null,"abstract":"Cerebral ischemia-reperfusion injury (CIRI) refers to a pathological phenomenon that aggravates the injury after the restoration of blood perfusion and oxygen supply to the cerebral ischemia-induced tissues and organs, with a relatively high incidence. The traditional Chinese medicine (TCM) believes that Qi deficiency and blood stasis are the cause of CIRI. Therefore, Chinese medicine for tonifying Qi and activating blood is regarded as an important choice for the treatment of CIRI. In recent years, it has been found that many Chinese herbal medical ingredients and compound Chinese medicine (CCM) have significant anti-CIRI effects, and their mechanisms of action mainly include improving brain blood supply, neuroprotection, regulating signal pathways such as TLR4/HO-1/Bcl-2, protecting mitochondrial function, regulating related protein levels, and regulating oxidative molecule levels. This article summarizes and introduces the pharmacological mechanisms of Tonifying-Qi and activating-blood Chinese medicine and CCM which have the function of anti-CIRI. Our goal is to provide effective reference for further researches on the cerebral protection of related TCMs or compounds and their clinical application.","PeriodicalId":23692,"journal":{"name":"World Journal of Traditional Chinese Medicine","volume":"8 1","pages":"225 - 235"},"PeriodicalIF":4.3000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Traditional Chinese Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/wjtcm.wjtcm_21_21","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 2

Abstract

Cerebral ischemia-reperfusion injury (CIRI) refers to a pathological phenomenon that aggravates the injury after the restoration of blood perfusion and oxygen supply to the cerebral ischemia-induced tissues and organs, with a relatively high incidence. The traditional Chinese medicine (TCM) believes that Qi deficiency and blood stasis are the cause of CIRI. Therefore, Chinese medicine for tonifying Qi and activating blood is regarded as an important choice for the treatment of CIRI. In recent years, it has been found that many Chinese herbal medical ingredients and compound Chinese medicine (CCM) have significant anti-CIRI effects, and their mechanisms of action mainly include improving brain blood supply, neuroprotection, regulating signal pathways such as TLR4/HO-1/Bcl-2, protecting mitochondrial function, regulating related protein levels, and regulating oxidative molecule levels. This article summarizes and introduces the pharmacological mechanisms of Tonifying-Qi and activating-blood Chinese medicine and CCM which have the function of anti-CIRI. Our goal is to provide effective reference for further researches on the cerebral protection of related TCMs or compounds and their clinical application.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
益气活血中药抗脑缺血再灌注损伤的药理机制研究进展
脑缺血再灌注损伤(Cerebral ischemic -reperfusion injury, CIRI)是指脑缺血引起的组织器官恢复血液灌注和供氧后损伤加重的病理现象,发病率较高。中医认为气虚血瘀是CIRI的病因。因此,补气活血中药被认为是治疗CIRI的重要选择。近年来,人们发现许多中草药成分和复方中药(CCM)具有显著的抗ciri作用,其作用机制主要包括改善脑血供、保护神经、调节TLR4/HO-1/Bcl-2等信号通路、保护线粒体功能、调节相关蛋白水平、调节氧化分子水平等。本文对补气活血中药及具有抗ciri作用的中药的药理机制进行了综述和介绍。目的是为进一步研究相关中药或化合物的脑保护作用及其临床应用提供有效参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
World Journal of Traditional Chinese Medicine
World Journal of Traditional Chinese Medicine Medicine-Complementary and Alternative Medicine
CiteScore
5.40
自引率
2.30%
发文量
259
审稿时长
24 weeks
期刊最新文献
Efficacy and safety of huachansu capsules for the treatment of esophageal cancer: A systematic review and meta-analysis Shenyi capsule prolongs postoperative survival of patients with nonsmall cell lung cancer: A multicenter, randomized, controlled trial Potential of essential oils as alternative permeation enhancers for transdermal delivery Research progress on Rodgersia and predictive analysis on its quality markers Symptom assessment and management in patients with lung cancer undergoing conventional or traditional chinese medicine care
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1